AKT1 and hepatocellular carcinoma: In our study, HCC cells after insufficient RFA exhibited higher expression of p-Akt and p-ERK1/2, and PI3K inhibitor, LY294002, and ERK inhibitor, PD98059, significantly inhibited the expression of p-Akt and p-ERK1/2 respectively.